JanOne sees every day as an opportunity for fresh ideas to end the opioid epidemic, the worst drug crisis in our nation’s history.
As a NASDAQ-listed company, JanOne draws private-sector resources into this urgent fight. We seek innovative treatments—focusing on developing revolutionary, non-addictive drugs that kill pain, not people.
March is National Autoimmune Disease month and as we are fighting an “invisible epidemic”, it is a great time to bring awareness. Approximately 23.5 million Americans are affected across the country, according to the NIH.